Unknown NA INTERVENTIONAL 4-arm NCT06020651

Vascular Toxicities of Immune ChecKpoint Inhibitors : From Bed to Benchside (VICKI)

Sponsor: Institut Mutualiste Montsouris

Conditions Bladder Cancer Cancer MSI-H Cancer Renal Cell Carcinoma

Interventions Arterial Doppler for Flow Mediated Reserve measurement

Updated 4 times since 2023 Last updated: Aug 29, 2023 Started: Jun 7, 2023 Primary completion: Dec 30, 2024 Completion: Jun 1, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06020651, this NA trial focuses on Bladder Cancer and Cancer and remains ongoing. Sponsored by Institut Mutualiste Montsouris, it has been updated 4 times since 2023, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

4 versions recorded

Aug 2025 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Aug 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Sep 2023 — Jul 2024 [monthly]

Recruiting NA

First recorded

Jun 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institut Mutualiste Montsouris
Institut National de la Santé Et de la Recherche Médicale, France

Data source: Institut Mutualiste Montsouris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France